Aprea Therapeutics, Inc. (APRE) Reports Q2 Loss, Tops Revenue Estimates
APREAprea Therapeutics(APRE) ZACKS·2024-08-12 22:45

Aprea Therapeutics, Inc. (APRE) came out with a quarterly loss of 0.58pershareversustheZacksConsensusEstimateofalossof0.58 per share versus the Zacks Consensus Estimate of a loss of 0.64. This compares to loss of 0.87pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof9.380.87 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 9.38%. A quarter ago, it was expected that this company would post a loss of 0.78 per share when it actually produced a loss of $0.67, delivering a surprise of 14.10%.Over the last four quarters, the company has ...